streptonigrin has been researched along with Malignant Melanoma in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (66.67) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boger, DL | 1 |
| Yasuda, M | 1 |
| Mitscher, LA | 1 |
| Drake, SD | 1 |
| Kitos, PA | 1 |
| Thompson, SC | 1 |
| Sztiller-Sikorska, M | 1 |
| Koprowska, K | 1 |
| Majchrzak, K | 1 |
| Hartman, M | 1 |
| Czyz, M | 1 |
| Gavriil, M | 1 |
| Tsao, CC | 1 |
| Mandiyan, S | 1 |
| Arndt, K | 1 |
| Abraham, R | 1 |
| Zhang, Y | 1 |
| HARRIS, MN | 1 |
| MEDREK, TJ | 1 |
| GOLOMB, FM | 1 |
| GUMPORT, SL | 1 |
| POSTEL, AH | 1 |
| WRIGHT, JC | 1 |
| JACQUILLAT, C | 3 |
| BOIRON, M | 1 |
| WEILL, M | 1 |
| MAZELIER, A | 1 |
| BERNARD, J | 1 |
| Banzet, P | 2 |
| Maral, J | 2 |
| Civatte, J | 1 |
| Puissant, A | 1 |
| Cottenot, F | 1 |
| Israel, L | 1 |
| Belaich, S | 1 |
| Chastang, C | 1 |
| Steels, EL | 1 |
| Watson, K | 1 |
| Parsons, PG | 1 |
| Garim, AM | 1 |
| Lorie, IuI | 1 |
| Reĭzinger, MA | 1 |
| Shkarenkov, VA | 1 |
| Durnov, LA | 1 |
2 trials available for streptonigrin and Malignant Melanoma
| Article | Year |
|---|---|
Clinical trials of chemotherapy and chemoimmunotherapy in primary malignant melanoma.
Topics: Clinical Trials as Topic; Dacarbazine; Drug Administration Schedule; Drug Therapy, Combination; Fema | 1982 |
[Preliminary results of clinical trial of the antineoplastic antibiotic bruneomycin].
Topics: Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Child; Child, Preschool; Clinical Trials as To | 1967 |
7 other studies available for streptonigrin and Malignant Melanoma
| Article | Year |
|---|---|
Streptonigrin and lavendamycin partial structures. Probes for the minimum, potent pharmacophore of streptonigrin, lavendamycin, and synthetic quinoline-5,8-diones.
Topics: Animals; Antibiotics, Antineoplastic; Chemical Phenomena; Chemistry, Physical; Leukemia L1210; Melan | 1987 |
Natural compounds' activity against cancer stem-like or fast-cycling melanoma cells.
Topics: Apoptosis; Biological Products; Cell Cycle Checkpoints; Cell Survival; Colony-Forming Units Assay; D | 2014 |
Specific IKKbeta inhibitor IV blocks Streptonigrin-induced NF-kappaB activity and potentiates its cytotoxic effect on cancer cells.
Topics: Antibiotics, Antineoplastic; Blotting, Western; Caspases; Cell Proliferation; DNA Damage; Enzyme Inh | 2009 |
CHEMOTHERAPY WITH STREPTONIGRIN IN ADVANCED CANCER.
Topics: Adenocarcinoma; Anti-Bacterial Agents; Antineoplastic Agents; Astrocytoma; Carcinoma, Basal Cell; Ca | 1965 |
[RESULTS OF THE TREATMENT OF MALIGNANT BLOOD DISEASES WITH RUFOCROMOMYCIN (RP 5278). APROPOS OF 57 CASES].
Topics: Anti-Bacterial Agents; Antineoplastic Agents; Blood Proteins; Drug Therapy; Hematologic Diseases; Ho | 1965 |
Adjuvant chemotherapy or chemoimmunotherapy in the management of primary malignant melanoma of level III, IV, or V.
Topics: Adult; Age Factors; Aged; Antineoplastic Agents; Bacterial Vaccines; BCG Vaccine; Dacarbazine; Drug | 1978 |
Relationships between thermotolerance, oxidative stress responses and induction of stress proteins in human tumour cell lines.
Topics: Adaptation, Physiological; Cell Survival; Heat-Shock Proteins; HeLa Cells; Heme Oxygenase (Decyclizi | 1992 |